Inventor · disambiguated record
Ansgar Santel
Also filed as: SANTEL ANSGAR · SANTEL ANSGAR H
9 granted patents·6 pending applications·29 citations·filing 2002–2017
85Inventor score
Files withSILENCE THERAPEUTICS GMBH5SILENCE THERAPEUTICS AG4GOSSEN MANFRED1KAUFMANN JORG1KEIL OLIVER1
Top patents by PatentIndex Score
15 records- 0190US8357722B2Lipids, lipid complexes and use thereofSilence Therpeutics AG·Filed 2011·Granted Jan 22, 2013·8 cites·17 claims
- 0288US9486538B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS GMBH·Filed 2015·Granted Nov 8, 2016·3 cites·14 claims
- 0383US8735453B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS AG·Filed 2013·Granted May 27, 2014·2 cites·13 claims
- 0480US9125820B2Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS AG·Filed 2014·Granted Sep 8, 2015·1 cites·6 claims
- 0579US6953680B2Mitofusins, Fzo Homologs and functional derivatives thereofUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Oct 11, 2005·9 cites·8 claims
- 0673US8232256B2Means for inhibiting the expression of protein kinase 3KAUFMANN JORG·Filed 2007·Granted Jul 31, 2012·4 cites·53 claims
- 0767US8722875B2Means for inhibiting the expression of Orc-1GOSSEN MANFRED·Filed 2009·Granted May 13, 2014·1 cites·21 claims
- 0864US2017036990A1Lipids, lipid complexes and use thereofSILENCE THERAPEUTICS GMBH·Filed 2016·Application pending·0 cites
- 0958US8829179B2Means for inhibiting the expression of ANG2SANTEL ANSGAR·Filed 2010·Granted Sep 9, 2014·1 cites·24 claims
- 1056US2011294871A1Lipids, lipid complexes and use thereofKEIL OLIVER·Filed 2011·Application pending·0 cites
- 1152US2014249207A1Means for inhibiting the expression of orc-1SILENCE THERAPEUTICS GMBH·Filed 2014·Application pending·0 cites
- 1252US2009074852A1Lipoplex formulations for specific delivery to vascular endotheliumSILENCE THERAPEUTICS AG·Filed 2007·Application pending·0 cites
- 1349US9458461B2Means for inhibiting the expression of ANG2SILENCE THERAPEUTICS GMBH·Filed 2014·Granted Oct 4, 2016·0 cites·15 claims
- 1446US2017296469A1Lipoplex formulations for specific delivery to vascular endotheliumSILENCE THERAPEUTICS GMBH·Filed 2017·Application pending·0 cites
- 1544US2009252783A1Means for inhibiting the expression of cd31SILENCE THERAPEUTICS AG·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ansgar Santel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →